Lawrence G. Lum, MD, DSc | Authors

Immunotherapy Prior to Stem Cell Transplant in Multiple Myeloma

December 10, 2013

In a 12-patient multiple myeloma pilot study, researchers demonstrated that anti-CD3 and anti-CD20 bispecific antibody (CD20Bi) activated both cellular and humoral anti-myeloma immunity that was detectable after patients received an autologous stem cell transplant.